The global anti-aging drugs for dogs market, valued at USD 0.09 billion in 2026, is projected to reach USD 6.16 billion by 2040, with a 36% CAGR during the forecast period 2026 to 2040. Over the years, the pet dog population has increased at a substantial rate. According to the American Veterinary Medical Association, the dog population has steadily increased from 52.9 million in 1996 to 89.7 million in 2024. Also, the number of pet-owning households has increased from 31.3 million in 1996 to 59...

The global female sexual dysfunction market reached USD 0.61 billion in 2026 and is projected to reach USD 2.87 billion by 2040, growing at a CAGR of 11.7% over the forecast period 2026 to 2040, driven by broader treatment eligibility and delivery innovation. Treatment demand is shifting from menopause-centered symptom management toward broader desire, arousal, pain, and orgasm-focused care. Estrogen therapy still leads drug demand with 41.0% share in 2026, while oral therapies hold 58.0% across...

The global non-small cell lung cancer market size is estimated to grow from USD 23.8 billion in 2025 to USD 26.4 billion in 2026 and USD 56.0 billion by 2035, representing a CAGR of 8.7% during the forecast period. It is worth highlighting that among all the forms of non-small cell lung cancer, squamous cell carcinoma is one of the most common types and it may develop due to prolonged use of tobacco. In fact, the World Health Organization report shows that smoking is the main cause of lung cance...

The global medication adherence market, valued at USD 5.45 billion in 2025, is projected to reach USD 6.08 billion in 2026 and USD 15.35 billion by 2035, representing a CAGR of 10.92% during the forecast period 2026 to 2035. In May 2026, Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, announced its participation at the BofA Securities 2026 Healthcare Conference. In January 2026, MIT engineers developed ingestible pills equipped with biod...

The global infusion pumps market size is valued at USD 13.90 billion in 2025 and projected to grow from USD 14.87 billion 2026 to USD 25.39 billion in 2035, representing a CAGR of 6.1% during the forecast period 2026 to 2035. In terms of device type, volumetric pumps currently hold the largest share (30%) due to their high precision, safety, versatility, and broad applications in healthcare (including blood infusion, drug administration, fluid transmission during surgeries, nutrient delivery). A...

The global prescription DTx market is expected to rise from USD 5.8 billion in 2026 to reach USD 75.0 billion by 2040, growing at a CAGR of 20.1% over the forecast period 2026 to 2040, driven by reimbursement pathways, FDA-cleared software therapies, and chronic-care digitization. Based on geography, North America captures 44.0% market share in 2026, whereas Asia-Pacific registers a 23.0% CAGR through 2040, driven by localized reimbursement and regulatory pathways. Based on application, diabetes...

The global GLP-1 manufacturing market is expected to rise from USD 14.6 billion in 2026 to reach USD 88.5 billion by 2040, growing at a CAGR of 13.7% over the forecast period 2026 to 2040, driven by chronic obesity and cardiometabolic demand. Based on manufacturing stage, drug substance / peptide API synthesis captures 35.0% market share in 2026, whereas device assembly and secondary packaging registers a 16.5% CAGR through 2040, driven by pen and combination-product scale-up. Based on manufactu...

The global stroke AI market is expected to rise from USD 0.44 billion in 2026 to reach USD 8.05 billion by 2040, growing at a CAGR of 23.1% over the forecast period 2026 to 2040, driven by time-critical stroke detection, care-team activation, and automated treatment-routing workflows. Based on offering, AI imaging and triage software captures 47.0% market share in 2026, whereas analytics and performance-management services register a 28.4% CAGR through 2040, driven by outcomes tracking. Based on...

The global cell encapsulation market, valued at USD 5.0 billion in 2025, is projected to reach USD 5.7 billion in 2026 and USD 15.8 billion by 2035, representing a CAGR of 12.0% during the forecast period 2026 to 2035. In April 2026, Atelerix signed a strategic partnership agreement with JH Health to expand the distribution and use of its proprietary non-cryogenic hydrogel encapsulation and cell preservation technology in the Middle East. In March 2026, researchers at MIT published findings on a...

The small molecule API manufacturing market, valued at USD 197 billion in 2025, is projected to reach USD 204 billion in 2026 and USD 266 billion by 2035, representing a CAGR of 3.0% during the forecast period 2026 to 2035. In terms of type of manufacturers, the in-house manufacturers are likely to secure ~65% of the overall revenue share in 2026, due to the growing preference towards large, vertically integrated pharmaceutical companies. In March 2026, Cambrex announced the initial completion o...

The global male contraceptives market is expected to rise from USD 16.5 billion in 2026 to reach USD 38.6 billion by 2040, growing at a CAGR of 6.3% over the forecast period 2026 to 2040, driven by reversible product innovation. Based on duration of action, single-use coital methods capture 72.0% market share in 2026, whereas on-demand pharmacological methods register a 38.3% CAGR through 2040, reducing adherence burdens. Based on distribution channel, drugstores and retail pharmacies capture 33...

The global viral vector and plasmid DNA manufacturing market, valued at USD 843 million in 2025, is projected to reach USD 937 million in 2026 and USD 2,161 million by 2035, with a CAGR of 9.73% during the forecast period 2026 to 2035. Presently, over 300 industry and non-industry players across the globe are actively involved so as to support the expanding pipeline of cell therapies, gene therapies, and vector-based vaccines, as per viral vectors and plasmid DNA manufacturing market report. In...

The global peptide synthesis market, valued at USD 3.8 billion in 2025, is projected to reach USD 4.2 billion in 2026 and USD 6.0 billion by 2035, at a CAGR of 4.1% during the forecast period 2026 to 2035. The generics segment secures 88% of the overall revenue share primarily due to the patent expirations of first-generation peptide drugs and high costs associated with branded therapies. In terms of type of peptide synthesis method, chemical synthesis method currently holds 85% of the overall m...

The global T-Cell Engagers Market reached USD 8.6 billion in 2026 and is projected to reach USD 62.5 billion by 2040, growing at a CAGR of 15.2% over the forecast period 2026 to 2040, driven by expanding hematologic approvals and early solid-tumor validation. Hematology-led adoption has shifted the T-cell engagers market from niche leukemia use toward broader CD3-directed bispecific commercialization. CD20, BCMA, and GPRC5D products now anchor demand across lymphoma and myeloma. DLL3 validation...

The back of the eye disorders market, valued at USD 17.06 billion in 2025, is projected to reach USD 18.28 billion in 2026 and USD 41.56 billion by 2035, representing a CAGR of 9.6% during the forecast period 2026 to 2035. Kindly note that implants and devices related to the back of the eye disorders market have been excluded from the scope of this report. In terms of geographical regions, North America captures around 60% of the market value in the year 2026, due to strong public and private i...

The global AI in medical scribing market reached USD 1.82 billion in 2026 and is projected to reach USD 22.3 billion by 2040, growing at a CAGR of 19.6% over the forecast period 2026 to 2040, driven by clinician burnout reduction and EHR-native ambient documentation. Ambient clinical documentation is moving from transcription replacement to EHR-integrated clinical workflow automation. Hospitals first bought AI medical scribe software to reduce note burden and after-hours charting.

The global triage system market is estimated at USD 9.8 billion in 2026 and is projected to reach USD 42.2 billion by 2040, growing at a CAGR of 11.0% over the forecast period 2026 to 2040, driven by AI-enabled emergency department prioritization, virtual front-door triage, and EHR-integrated decision-support tools. Regulatory classification and workflow validation slow adoption because triage tools influence patient routing and clinical prioritization. Infermedica’s September 2025 MDR Class I...

The global biopharmaceutical excipients manufacturing market, valued at USD 3.3 billion in 2025, is projected to reach USD 3.6 billion in 2026 and USD 6.3 billion by 2035, representing a CAGR of 6.4% during the forecast period 2026 to 2035. Emerging innovations, particularly in lipid-based excipients for mRNA vaccines and therapeutics, are further expanding the excipient landscape. Coupled with the rising trend in outsourcing and growing regulatory support for novel excipients, the use of biopha...

The global AI in medical coding market is expected to rise from USD 3.4 billion in 2026 and reach USD 16.2 billion by 2040, growing at a CAGR of 11.8% over the forecast period 2026 to 2040, driven by revenue cycle automation and coder productivity pressure. Based on Component, Software platforms is both the dominant and fastest-growing category, holding 72.0% share in 2026 and expanding at 12.4% CAGR through 2040, driven by scalable autonomous coding engines. Compliance exposure restrains autono...

The global atrial fibrillation treatment devices market, valued at USD 7.9 billion in 2025, is projected to reach USD 9.6 billion in 2026 and USD 29.0 billion by 2035, representing a CAGR of 13.1% during the forecast period 2026 to 2035. Atrial fibrillation currently affects tens of millions of individuals worldwide, with global prevalence estimates exceeding 50 million cases. Driven by the aging populations and growing prevalence of hypertension, obesity, diabetes, and unhealthy lifestyles, the...